The government has proposed extending the compliance deadline for revised Schedule M norms for pharmaceutical manufacturing.

Let's look at the transformative impact of AI and ML on financial risk management, their potential and the challenges that ...

As the pharmaceutical industry ... pose potential problems for companies in the industry. This makes the need for effective security and risk management ever more important – and an intelligence ...

The pharmaceutical industry is among the most heavily ... companies are using NLP to improve regulatory compliance activities. Data-driven risk management: The biopharma product development ...

Nearly half of India's 10,000 drug manufacturing units might not meet the 2025 deadline for upgrading to revised Schedule M ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Ivalua, a global leader in spend management, and its partner integrator Fluxym, today announced that Laboratoires Théa (Théa) ...

"The state FDA has formed a team in collaboration with the central team to encompass those factories omitted in the risk-based inspection ... and the state's pharma industry contributes ...

The “Vietnam Post Operative Nausea and Vomiting Market ” offers a quantitative analysis of the relevant industry. Quantitative research is data-driven and looks for pertinent patterns in data acquired ...

With clinical trials facing multiple challenges, digital solutions could provide the answer. We identify the key trends to watch in 2025.

Partnerships with Incident Response Leaders Palo Alto Networks Unit 42, Arctic Wolf, Sophos, Fenix24, and Semperis Speed ...

The Department of Health and Human Services, Office of Inspector General (“OIG”) recently released a favorable advisory opinion, OIG Advisory ...